HIMS Commentator
TSLL Gain HunterLilly's GLP-1 tablet has a self-pay price starting at $149. It will launch on LillyDirect on April 6th, and soon after will be widely available through U.S. retail pharmacies and telemedicine channels. It is currently unclear whether HIMS will offer this service. Foundayo is the first new molecular entity (NME) approved under the National Priority Voucher (CNPV) pilot program. Foundayo is the only GLP-1 medication that can be taken at any time of day without food or water restrictions. Novo Nordisk's Wegovy tablet must be taken on an empty stomach in the morning, with a small sip (up to 4 ounces) of plain water. After taking it, patients must wait 30 minutes before eating, drinking, or taking other medications.$Hims & Hers Health(HIMS.US) $Defiance Daily Target 2X Long HIMS ETF(HIMZ.US)
The FDA just approved Eli Lilly's (LLY) once-daily GLP-1 weight-loss drug Foundayo. "People with insurance can use Eli Lilly's coupon to pay $25 per month, while self-pay patients may need to pay between $149 and $349, depending on the dosage." — CNBC. Novo Nordisk started to skid...$Hims & Hers Health(HIMS.US) $Defiance Daily Target 2X Long HIMS ETF(HIMZ.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
